We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.50 | 0.22% | 1,587.00 | 1,586.50 | 1,587.50 | 1,588.50 | 1,575.00 | 1,579.50 | 1,156,028 | 14:42:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.24 | 65.23B |
Date | Subject | Author | Discuss |
---|---|---|---|
19/10/2020 15:40 | I've been adding today, the S/P will only get better, plus the Divi not bad either. | igoe104 | |
18/10/2020 20:18 | I was a couple of hours early with my investment on Thursday, but pleased with the rebound on Friday. With the Pfizer news, pharma stocks should see sharp rises in the coming weeks. | shammytime | |
18/10/2020 11:07 | Lol, that's why your never hear of a rich chartist. | montyhedge | |
16/10/2020 21:47 | Double head n shoulder no dandruff | williamcooper104 | |
16/10/2020 21:31 | Old Chinese ploverb say : Man with 2 legs walk faster than man with one....Hard to argue. spud | spud | |
16/10/2020 20:42 | Tea leaves say............. | badtime | |
16/10/2020 19:50 | Chart says 1300. | djb3 | |
16/10/2020 18:02 | jade - historical reasons if I may ask? My bearish positions were slightly larger at one time. ;)) | alphorn | |
16/10/2020 17:17 | And imo .. will go to 1500 ! Then make a decision | amaretto1 | |
16/10/2020 17:15 | It played the chart spot on to 13.75It should carry on riseing from here. | amaretto1 | |
16/10/2020 17:02 | GSK is if anything negatively correlated to the Great British Peso Will have a higher GBP cost base which will be less relative to its much larger USD and EUR revenue streams There's a lot of US life science interest in the U.K. which is based on our scientists being cheaper in USD terms and likely to get cheaper | williamcooper104 | |
16/10/2020 16:57 | Glaxo is U.K. listed and headquartered - but that's it - not a domestic company | williamcooper104 | |
16/10/2020 16:55 | Inflation resilient assets and a good accountant | williamcooper104 | |
16/10/2020 16:39 | Porsche, lol, his got a skateboard. | montyhedge | |
16/10/2020 16:27 | Spent it all attempting to keep his ropey Porsche 924 on the road.....spud | spud | |
16/10/2020 15:33 | Lol he has not got one single share. His a dreamer. | montyhedge | |
16/10/2020 15:32 | P1945, can’t understand why you own so many GSK shares ( you said you had many more than me and I own more than £0.5 million worth) and yet you always seem to berate them! | jadeticl3 | |
16/10/2020 15:16 | Does it cannibalise current treatment? (Not belittling the positive impact for patients). | alphorn | |
16/10/2020 15:07 | In a normal market, with that rns these would have been 1550p. | montyhedge | |
16/10/2020 14:34 | ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV -- ViiV Healthcare's Vocabria (cabotegravir injection) used in combination with Janssen Pharmaceutical Companies of Johnson & Johnson's Rekambys (rilpivirine injection) reduces treatment dosing days from 365 to 12 or 6 per year -- Long-acting regimen is based on co-administration of cabotegravir and rilpivirine injections once-monthly or once every 2-months to treat HIV-1 -- Vocabria (cabotegravir) tablets for use as an oral lead-in therapy with Edurant (rilpivirine tablets) prior to starting the long-acting regimen also receives positive CHMP opinion | tradermichael | |
16/10/2020 12:09 | Thanks bears for my early Xmas present yesterday. Could not believe the price. | montyhedge | |
16/10/2020 09:46 | Unreasonably low. Might drop a bit further next week tho with boris the bozo and his negotiating skills, but feels like near the bottom. For LT investor anytime now is a good time to go in I reckon | bogman1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions